Abstract:Diabetes mellitus is a chronic metabolic disorder marked by hyperglycemia and systemic complications, including hepatic dysfunction, significantly contributing to disease progression and morbidity. This article reviews recent advances in gene-based therapeutic strategies targeting hepatic complications in diabetes, offering a promising approach for precision medicine by addressing underlying molecular mechanisms. Traditional treatments for hepatic complications in diabetes often manage symptoms rather than molecular causes, showing limited efficacy. Gene-based therapies are poised to correct dysfunctional pathways and restore hepatic function. Fundamental gene therapy approaches include gene silencing via small interfering RNAs (siRNAs) to target hepatic glucose production, lipid metabolism, and inflammation. Viral vectors can restore insulin sensitivity and reduce oxidative stress in diabetic livers. Genome editing, especially CRISPR-Cas9, allows the precise modification of disease-associated genes, offering immense potential for hepatic complication treatment. Strategies using CRISPR-Cas9 to enhance insulin receptor expression and modulate aberrant lipid regulatory genes are explored. Safety challenges in gene-based therapies, such as off-target effects and immune responses, are discussed. Advances in nanoparticle-based delivery systems and targeted gene editing techniques offer solutions to enhance specificity and minimize adverse effects. In conclusion, gene-based therapeutic approaches are a transformative direction in managing hepatic complications in diabetes. Further research is needed to optimize efficacy, safety, and long-term outcomes. Nevertheless, these innovative strategies promise to improve the lives of individuals with diabetes by addressing hepatic dysfunction's genetic root causes.

Liver‐directed gene therapy for inherited metabolic diseases

Gene Therapy for Inherited Liver Disease: To Add or to Edit

Liver gene transfer for metabolite detoxification in inherited metabolic diseases

Drug-induced liver injury related to gene therapy: A new challenge to be managed

Therapeutic liver cell transplantation to treat a genetic liver defect

Novel Therapeutic Modalities For Hepatic Diseases

Gene editing technology as an approach to the treatment of liver diseases

Gene Therapy: Regulations, Ethics and Its Practicalities in Liver Disease

Gene Therapy for Liver Cancers: Current Status from Basic to Clinics

Therapeutic liver cell transplantation to treat murine PKU

Adeno-associated viruses for gene therapy - clinical implications and liver-related complications, a guide for hepatologists

Novel gene-based therapeutic approaches for the management of hepatic complications in diabetes: Reviewing recent advances

Advancing Liver Gene Therapy: Enhanced Transduction with GalNAc-Bioconjugated rAAV Capsids

In vivo liver targeted genome editing as therapeutic approach: progresses and challenges

Adeno-associated viral vectors for correction of inborn errors of metabolism: progressing towards clinical application.

Exploiting the unique regenerative capacity of the liver to underpin cell and gene therapy strategies for genetic and acquired liver disease

Liver health in hemophilia in the era of gene therapy

Recent Advances in Liver-Directed Gene Transfer Vectors.

Gene therapy for mitochondrial disorders

Current and Future Prospects for Gene Therapy for Rare Genetic Diseases Affecting the Brain and Spinal Cord

Adeno-Associated Virus Gene Therapy for Liver Disease